We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Long-Term ECG Monitoring Helps Diagnose Atrial Fibrillation

By HospiMedica International staff writers
Posted on 12 Apr 2012
A wireless ambulatory monitoring system offers electrophysiologists and cardiologists the advantages of both a Holter electrocardiogram (ECG) and cardiac event monitor in one device.

The TruVue ECG Monitoring System is intended for the diagnosis and management of atrial fibrillation (AF) and other complex cardiac arrhythmia, as well as serving as a platform for pharmaceutical and medical device companies to assess the cardiovascular safety and efficacy associated with new drugs and devices. More...
The system’s diagnostic benefits include the ability to record and wirelessly transmit every heartbeat for up to 30 days; perform advanced arrhythmia analysis; and to provide immediate online access to all transmitted ECG data.

The patented technology employs cellular communication to transmit recordings of every heartbeat to secure servers, where proprietary algorithms analyze the incoming data for changes in morphology, rate, or rhythm. Patients can also initiate alerts when symptoms are experienced. Certified cardiac technicians validate the findings, post reports in real time, and alert physicians based on cardiac events or notification criteria. At any time, physicians can access information online, including any portion of the recorded ECG monitoring and trend reports detailing 24-hour heart rate and rhythm abnormalities, including AF. The TruVue ECG Monitoring System is a product of Biomedical Systems (St. Louis, MO, USA).

“TruVue expedites the diagnoses of patients who may have cardiac arrhythmia, including atrial fibrillation, by delivering the most comprehensive long-term view of the heart rhythm,” said Jim Ott, president of the cardiology division at Biomedical Systems. “With TruVue, we provide physicians with the unique ability to review every heartbeat for up to 30 days, combining both algorithm-triggered ECG-recordings and episodes recorded by patients, and immediately access information online without working through support staff.”

A Holter monitor (named for physicist Dr. Norman J. Holter, who invented telemetric cardiac monitoring in 1949) is a portable device for continuously monitoring various electrical activity of the cardiovascular system or monitoring brain activity for at least 24 hours (often for two weeks at a time). The extended recording period is useful for observing occasional cardiac arrhythmias or epileptic events, which would be difficult to identify in a shorter period of time. For patients having more transient symptoms, a cardiac event monitor, which can be worn for a month or more, can be used.

Related Links:
Biomedical Systems


New
Gold Member
Handheld Blood Glucose Analyzer
STAT-Site
New
Gold Member
Neonatal Heel Incision Device
Tenderfoot
New
Resorbable Bovine Collagen Membrane
GenDerm
New
Surgical System
Stealth AXiS
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Six-month FlexPulse IDE data show positive outcomes with Abbott’s TactiFlex Duo catheter, confirming safety and efficacy seen in the CE Mark study for complex AFib (photo courtesy of Abbott)

Dual-Energy Ablation and Conduction System Pacing Show Positive Early Outcomes

Atrial fibrillation and other arrhythmias are common in both hospitalized and ambulatory patients, often complicating hemodynamic stability, stroke prevention, and perioperative care. Within this context,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.